Literature DB >> 1970148

Drug effects on REM sleep and on endogenous depression.

G W Vogel1, A Buffenstein, K Minter, A Hennessey.   

Abstract

In earlier work REM sleep deprivation (RSD) by arousals improved endogenous depression. This suggested that drugs producing a similar RSD would have antidepressant activity. The arousal RSD was large, persisted for weeks, and was followed by a REM rebound. We call RSD with these properties arousal-type RSD. The present study reviewed literature from 1962 to 1989 on drug REM sleep effects to examine the hypothesis that drugs producing arousal-type RSD improve endogenous depression. The literature reviewed concerned the REM sleep effects of amine precursors, antidepressants, antihistamines, antipsychotics, barbiturates, benzodiazepines, other hypnotics, drugs affecting cholinergic and noradrenergic neurotransmission, ethanol, lithium and narcotics. Four hundred and sixty-eight relevant papers were read and 215 contributed information that could be used in the review. The findings indicated that all drugs producing arousal-type RSD improved endogenous depression. Four drugs that improved endogenous depression did not produce arousal-type RSD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970148     DOI: 10.1016/s0149-7634(05)80159-9

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  22 in total

Review 1.  Hypnotics: an update.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

2.  Sleep Disturbances in Pediatric Depression.

Authors:  Uma Rao
Journal:  Asian J Psychiatr       Date:  2011-12

Review 3.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.

Authors:  D B Boivin
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 4.  Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.

Authors:  R Davis; R Whittington; H M Bryson
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

5.  The effect of clomipramine on wake/sleep and orexinergic expression in rats.

Authors:  P Feng; Y Hu; D Li; D Vurbic; H Fan; S Wang; K P Strohl
Journal:  J Psychopharmacol       Date:  2008-06-18       Impact factor: 4.153

6.  Sleep promotes generalization of extinction of conditioned fear.

Authors:  Edward F Pace-Schott; Mohammed R Milad; Scott P Orr; Scott L Rauch; Robert Stickgold; Roger K Pitman
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

Review 7.  Circadian rhythm disturbances in depression.

Authors:  Anne Germain; David J Kupfer
Journal:  Hum Psychopharmacol       Date:  2008-10       Impact factor: 1.672

8.  Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects.

Authors:  Stephan Chalon; Alvaro Pereira; Eric Lainey; François Vandenhende; John G Watkin; Luc Staner; Luc-André Granier
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

9.  Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram.

Authors:  A L van Bemmel; R H van den Hoofdakker; D G Beersma; A L Bouhuys
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.

Authors:  Thibaut Sesia; Brandon Bizup; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2013-01-29       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.